FDA approves Spevigo for pustular psoriasis

[Caroline]

Following on form this thread Spesolimab IL-36 for pustular psoriasis The U.S. Food and Drug Administration (FDA) has approved Spevigo for the treatment of generalized pustular psoriasis (GPP) flares in adults.

Really strange… they say…Below….. and they are treating the immune system….
So even in these pharma surroundings, they wrestle with if something is a skin disease or a disease that expresses on the skin.

Quote:

---

Distinct from plaque psoriasis, GPP is a rare and potentially life-threatening neutrophilic skin disease, characterized by episodes of widespread eruptions of painful, sterile pustules. Given that it is so rare, recognizing the symptoms can be challenging and consequently lead to delays in diagnosis.

Source: boehringer-ingelheim.com